Argen X Financials
| ARGX Stock | EUR 590.80 8.40 1.44% |
Argen |
Understanding current and past Argen X Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Argen X's financial statements are interrelated, with each one affecting the others. For example, an increase in Argen X's assets may result in an increase in income on the income statement.
Argen X Stock Summary
Argen X competes with Galapagos, UCB SA, Biocartis Group, and Melexis NV. argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Ltd, Universit Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., University of Texas, BioWa, Inc., Cilag GmbH International, Staten Biotechnology B.V., and Shire International GmbH. argenx SE was incorporated in 2008 and is based in Breda, the Netherlands. ARGENX SE operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange. It employs 650 people.| Foreign Associate | USA |
| Instrument | Belgium Stock View All |
| Exchange | Euronext Brussels |
| ISIN | NL0010832176 |
| Business Address | Willemstraat 5, Breda, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.argenx.com |
| Phone | 31 10 703 8441 |
| Currency | EUR - Euro |
You should never invest in Argen X without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Argen Stock, because this is throwing your money away. Analyzing the key information contained in Argen X's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Argen X Key Financial Ratios
There are many critical financial ratios that Argen X's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Argen X reports annually and quarterly.| Return On Equity | -0.31 | |||
| Return On Asset | -0.16 | |||
| Target Price | 440.25 | |||
| Number Of Employees | 650 | |||
| Beta | 0.47 |
Argen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Argen X's current stock value. Our valuation model uses many indicators to compare Argen X value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Argen X competition to find correlations between indicators driving Argen X's intrinsic value. More Info.Argen X is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Argen X's earnings, one of the primary drivers of an investment's value.Argen X Systematic Risk
Argen X's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Argen X volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Argen X correlated with the market. If Beta is less than 0 Argen X generally moves in the opposite direction as compared to the market. If Argen X Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Argen X is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Argen X is generally in the same direction as the market. If Beta > 1 Argen X moves generally in the same direction as, but more than the movement of the benchmark.
Argen X November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Argen X help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Argen X. We use our internally-developed statistical techniques to arrive at the intrinsic value of Argen X based on widely used predictive technical indicators. In general, we focus on analyzing Argen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Argen X's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.74 | |||
| Information Ratio | 0.1276 | |||
| Maximum Drawdown | 10.86 | |||
| Value At Risk | (2.14) | |||
| Potential Upside | 3.5 |
Additional Tools for Argen Stock Analysis
When running Argen X's price analysis, check to measure Argen X's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Argen X is operating at the current time. Most of Argen X's value examination focuses on studying past and present price action to predict the probability of Argen X's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Argen X's price. Additionally, you may evaluate how the addition of Argen X to your portfolios can decrease your overall portfolio volatility.